Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 24
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06043921 | Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel | ||
| NCT04465968 | Efficacy and Safety of CRT, Durvalumab and Surgery for SST | ||
| NCT04745988 | An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib with Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients with Gastric Cancer | ||
| NCT05694819 | Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) | ||
| NCT04457297 | Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection | ||
| NCT05394740 | Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | ||
| NCT02410369 | Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer | ||
| NCT04879368 | RegoNivo vs Standard of Care Chemotherapy in AGOC | ||
| NCT03480373 | Electronic Cigarette Use During Pregnancy | ||
| NCT03609359 | Lenvatinib and Pembrolizumab Simultaneous Combination Study | ||
| NCT02851004 | Special Combination of BBI608 and Pembrolizumab | ||
| NCT03000751 | CT DOSE Collaboratory | ||
| NCT04417192 | Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer | ||
| NCT03172819 | Special Combination of OBP-301 and Pembrolizumab | ||
| NCT05034887 | Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma | ||
| NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | ||
| NCT05696548 | Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) | ||
| NCT04288999 | Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer | ||
| NCT02948348 | Study to Nivolumab Following Preoperative Chemoradiotherapy | ||
| NCT05646511 | TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer | ||
| NCT03406871 | Regorafenib and Nivolumab Simultaneous Combination Therapy | ||
| NCT07018570 | An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma | ||
| NCT04040361 | Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) | ||
| NCT07100704 | Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab |
